-
Immunovant (NASDAQ:IMVT) Upgraded by Cantor Fitzgerald to Strong-Buy Rating
Source: Buzz FX / 06 Mar 2025 07:32:12 America/Chicago
Immunovant (NASDAQ:IMVT) Upgraded by Cantor Fitzgerald to Strong-Buy Rating Written by MarketBeat March 6, 2025 Share Link copied to clipboard. Immunovant ( NASDAQ:IMVT - Get Free Report ) was upgraded by Cantor Fitzgerald to a "strong-buy"
Read more...